• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » KFx defeats Stryker challenge to shoulder anchor patent

KFx defeats Stryker challenge to shoulder anchor patent

September 17, 2019 By Brad Perriello

KFx Medical, StrykerUPDATED Sept. 18, 2019, with additional inter partes win for KFx.

KFx Medical yesterday defeated a challenge by Stryker (NYSE:SYK) to one of its patents covering orthopedic suture anchors when the U.S. Patent Trial & Appeals board declined to initiate an inter partes review.

U.S. patent no. 7,585,311, covering a “System and method for attaching soft tissue to bone,” was already the subject of lengthy battle between Carlsbad, Calif.-based KFx and Arthrex. After suing Arthrex in August 2011, KFx won more than $30 million in damages. A higher court denied Arthrex’s appeals; Arthrex later coughed up $35 million to satisfy the judgment and failed to convince the U.S. Supreme Court review the case. A New Jersey federal judge tossed a lawsuit later brought by Arthrex.

In March, Stryker asked the PTAB for inter partes review, challenging 21 claims of KFx’s ‘311 patent. Yesterday the patent trial board rejected the request, citing the patent surviving its initial prosecution and a subsequent re-examination and the Arthrex lawsuit.

“We find that the asserted art was not a basis for rejection during prosecution or reexamination,” according to the PTAB decision. “The Arthrex litigation and, specifically, the evidence of secondary considerations developed therein, weighs in favor of denying institution.

“Despite knowing of the Arthrex litigation, [Stryker] did not address the secondary considerations evidence in its petition. We have cautioned petitioners in prior proceedings that petitions may be denied if they do not address known evidence of secondary considerations. [Stryker’s] failure to address the known evidence of secondary considerations further weighs in favor of denying institution,” the board decided.

It’s the second win in as many months for KFx over Stryker, which issued an IPR challenge to U.S. patent no. 8,951,287, also covering a “System and method for attaching soft tissue to bone.” In an August 19 decision, the PTAB ruled against initiating the review because Stryker failed to show any evidence that an obviousness challenge could succeed.

Filed Under: Featured, Legal News, Orthopedics, Patent Infringement, Wall Street Beat Tagged With: KFx Medical, Stryker

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy